Moratorium on Gene Editing in human embryos

ESHRE supports the call for a moratorium on the use of CRISPR/Cas9 nucleases in the human embryo for clinical applications (Nature 567, 165-168 (2019)). This powerful genetic tool can be programmed easily to facilitate the correction of genetic mutations seamlessly and at high efficiency. Although the technology is already revolutionizing preclinical biomedical research, multiple independent reports have raised awareness that the CRISPR/Cas9 system can cause unexpected alterations to genomic DNA resulting in potentially damaging mutagenic events.

Infertility is linked to small increased risk of cancer

Human Reproduction Press Release
A study of over 64,000 women of childbearing age in the USA has found that infertility is associated with a higher risk of developing cancer compared to a group of over three million women without fertility problems, although the absolute risk is very low at just 2%

Euro GTP II interactive assessment tool

The online assessment tool of the project Euro GTP II is now online. The aim of the tool is to identify, assess and quantify the risks associated with the introduction of novel or modified procedures during tissues and cells preparation. The assessment tool is based on a structured methodology presented in the Euro GTP II guide.
More information about the Euro GTP II project can be found here.

Endometriosis awareness- A collection of key research from ESHRE

In support of Endometriosis Awareness Week UK starting 4 March 2019, we have curated the following selection of ESHRE articles on the topic of endometriosis. The journals' Editors have selected key papers, which will be freely available for you to explore in support of the awareness campaign.

Follow the latest news about reproductive science and medicine

Annual Meeting

ESHRE 2019 Vienna

ESHRE Journals

Patient partner organisation